Figure 2
Figure 2. IDO expression in AML cells increased CD4+CD25+Foxp3+ T cells. (A-B) Flow cytometry analysis of CD4+CD25+ T cells before and after culture with AML cells in the presence and absence of 1-MT (1000 μM). Data are expressed as the percentage of CD4+CD25+ T cells (A) and as CD25 MFI on gated CD4+ T cells (B). Results are the mean ± SD of 10 independent experiments. (C) Surface CTLA-4 expression on purified CD4+CD25+ T cells obtained after culture with IDO-expressing AML cells in the presence and absence of 1-MT. Results are representative of 4 independent experiments. (D) FOXP3 mRNA expression by purified CD4+CD25+ and CD4+CD25− T cells obtained after culture with IDO-expressing AML cells. Total MNCs stimulated with monoclonal antibodies against CD3 and CD28 were used as positive control. Results are representative of 4 independent experiments.

IDO expression in AML cells increased CD4+CD25+Foxp3+ T cells. (A-B) Flow cytometry analysis of CD4+CD25+ T cells before and after culture with AML cells in the presence and absence of 1-MT (1000 μM). Data are expressed as the percentage of CD4+CD25+ T cells (A) and as CD25 MFI on gated CD4+ T cells (B). Results are the mean ± SD of 10 independent experiments. (C) Surface CTLA-4 expression on purified CD4+CD25+ T cells obtained after culture with IDO-expressing AML cells in the presence and absence of 1-MT. Results are representative of 4 independent experiments. (D) FOXP3 mRNA expression by purified CD4+CD25+ and CD4+CD25 T cells obtained after culture with IDO-expressing AML cells. Total MNCs stimulated with monoclonal antibodies against CD3 and CD28 were used as positive control. Results are representative of 4 independent experiments.

Close Modal

or Create an Account

Close Modal
Close Modal